Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07246746
Recruiting Not applicable

Use of an Infotainment System in MRI in Patients Suffering From Unexpected Anxiety.

NCT07246746 · tracked via the Priya Life Science France tracker
Sponsor
Centre Hospitalier Universitaire Dijon
Phase
Not applicable
Started
2026-01-12
Last updated
2026-01-15

Condition(s) studied

Unexpected Anxiety

Investigational drug(s) / intervention(s)

Assessment of patient anxiety through self-administration of the State Anxiety Inventory Form Y-A questionnaireAnxiety support procedure according to randomization: Innovision© or Hypnosis

Assessment of patient anxiety through self-administration of the State Anxiety Inventory Form Y-A questionnaire: Assessment of patient anxiety

Anxiety support procedure according to randomization: Innovision© or Hypnosis: Hypnosis or Innovision device

Study summary

MRI scans are now considered essential for diagnosing or monitoring disease, and as a result, the number of MRI scans has increased significantly in recent years.

Nevertheless, these routine examinations remain a source of apprehension and anxiety for some people.

The objective of this study is to compare two methods of care, enabling anxious individuals to complete their MRI examination and obtain images of sufficient quality for the radiologist to read and interpret.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Individuals who have given their verbal consent * Individuals over the age of 18 * Hospitalized or ambulatory individuals who are able-bodied and scheduled to undergo a brain MRI scan on the 1.5T A MRI machine at the Dijon University Hospital. * Individuals reporting anxiety about brain MRI for the first time upon admission by the radiology technician. Exclusion Criteria: * Persons not affiliated with or not covered by a social security system * Persons subject to legal protection measures (guardianship, trusteeship) * Persons subject to judicial protection measures * Women who know they are pregnant * Adults who are incapable or unable to give their consent * Persons with contraindications to MRI * Persons who have already undergone an MRI accompanied by hypnosis * Persons who do not speak French * Persons who cannot read French * Persons with cognitive disorders * Persons who have taken sedatives before the examination * Persons who regularly take anxiolytic medication and have increased their usual dose before the examination * Persons who have already participated in the study

Primary outcome measure(s)

  • Percentage of brain MRI sequences reported as interpretable — Baseline

Trial sites (1)

FacilityCityRegionStatus
CHU Dijon Bourgogne Dijon France Recruiting

More Centre Hospitalier Universitaire Dijon trials in France

Oncology, Undernutrition and Sensoriality: Links, Mechanisms and Levers for Action Recruiting
Innovative Biomarkers of Cardiovascular Complications Associated With Second-generation Bruton Tyrosine Kinase Inhibitor Treatments: a Single-center Cohort Study Recruiting
Post-Resuscitation Interdisciplinary Consultation System: a Randomized, Multicenter, Interventional Study to Assess Quality of Life After a Stay in the COPRéa Intensive Care Unit Recruiting
Pupillometry vs. BPS (Behavioral Pain Scale) for Analgesia Management in Inpatient Intensive Care Unit Patients on Invasive Mechanical Ventilation Starting soon
Association Between Circulating BDNF Levels and Atrial Cardiomyopathy in Patients Undergoing Ablation for Persistent Atrial Fibrillation Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07246746 on ClinicalTrials.gov ↗ ← All trials in France